Genmab — Oktober 2017

[bibob]

Sgen steg 6,51 % og J&J 2,02 % i går. Måske det smitter af på os idag.

[GeorgeBest]

Eli Lilly fejler senfasestudie med lungekræftkandidat http://medwatch.dk/Medicinal___Biotek/article9941299.ece?utm_campaign=Morgen&utm_content=2017-10-12 08%3A14%3A48&utm_medium=top&utm_source=Feed

[E_L]

i guess that must have been the first time Genmab was mentioned by Jim Cramer ; what a milestone lol

[mobbyduck1]

nope Genmab has been mentioned several time with darzalex/JNJ

[Mcjean]

E L i couldnt find out yesterday about Nice but since they have there own organisation in Skotland i think they cant get treatment there only if they pay. I saw on forums in England that people pay by them self........not cheap.

[E_L]

no Jim-Cramer-milestone payment
then

[E_L]

ok- hadnt seen any forums there, guess that confirms your thoughts Mcjean. Most people will not be able to afford that...

[bibob]

Er der nogen der har en ide om hvad der kan være årsagen til alle de suspend og withdrawn der er på dette studie med Dara i NSCLC. ? https://clinicaltrials.gov/ct2/show/NCT03023423?term=Darzalex&recrs=ab&cond=Nsclc&rank=1

[GeorgeBest]

Det har fremme tidligere. Problemet ligger hos Atezolizumab.

[E_L]

yea, but the one that was halted by the FDA was in MM, NCT02431208 . Should we
assume now they dont want to risk it in NSCLC either -for now?

[bibob]

It could be a big risk. Better stop and no results than continue and fail.

[Sukkeralf]

But still lots of locations are recruiting

[Bulder]

tror ikke det har noget med pd-1/pd-l1 problemet at gøre. Det var i kombi med iMids. Det er snarere in-/exclusions kriterierne der er stramme. Og så er der 104 lokationer og de skal bruge 96 pts. Så det går nok.

[Bulder]

Men at det lige præcis er de tyske lokationer der er suspenderede ser mystisk ud.

[Sukkeralf]

Lidt interesse for Selinexor:

[Sukkeralf]

(investors.karyopharm.com)

[jkj]

mere info om dara/nice og det nye combi forsøg i Englandhttps://pharmaphorum.com/news/myeloma-uk-launches-stratified-medicine-trial-darzalex-combo/

[JørgenVarnæs]

Jan modsiger Florian i morgendagens Børsen ang overtagelse

[JørgenVarnæs]

Og giver en røffel til analytikerne for at have drukket af natpotten

[polle1]

Hvordan ved du det, Varnæs ? Har lige checket Børsen online, og jeg kan ikke se noget om det du skriver ???